Humira(CF) 40 MG/0.4 ML syrings
Ended Awarded Last action
- Contract number
- SPE2DR26F1LYY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,008
Award facts
- Contract value 100% obligated
- $10,007.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,007.63 to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL syringes. This firm fixed-price, competitively awarded contract involves no set-aside designation and is scheduled for completion by December 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime contract vehicle valued through December 2026 that provides comprehensive pharmaceutical and medical supply support to federal healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare procurement through the Defense Logistics Agency. The company maintains an extensive portfolio of federal contract awards encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas. The delivery of HUMIRA syringes under this contract supports the Department of Defense's medical supply chain, providing essential pharmaceutical products to the Defense Health Agency and other federal healthcare entities. As a leading pharmaceutical prime vendor for the DLA, AmerisourceBergen demonstrates established capability to fulfill federal medical procurement requirements through competitive acquisition processes.
Quick answers
Who was awarded contract SPE2DR26F1LYY?
SPE2DR26F1LYY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F1LYY worth?
The government has obligated $10,008 on SPE2DR26F1LYY.
Is contract SPE2DR26F1LYY an order under another contract?
Yes. SPE2DR26F1LYY is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1LYY competed?
The extent of competition for SPE2DR26F1LYY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award